Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 104 checked references that resolve
resolves10.1002/j.1460-2075.1987.tb02429.xMolecular cloning of sequences from wingless, a segment polarity gene in Drosophila: the spatial distribution of a transcript in embryos
resolves10.1038/emboj.2012.146Three decades of Wnts: a personal perspective on how a scientific field developed
resolves10.1038/nrc3419WNT signalling pathways as therapeutic targets in cancer
resolves10.1038/nrc2389Wnt signalling and its impact on development and cancer
resolves10.1038/nature10337Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling
resolves10.1074/jbc.M112.414441The Wnt Coreceptor Ryk Regulates Wnt/Planar Cell Polarity by Modulating the Degradation of the Core Planar Cell Polarity Component Vangl2
resolves10.1101/gad.1957710Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors
resolves10.1093/hmg/ddt277LRP6 exerts non-canonical effects on Wnt signaling during neural tube closure
resolves10.1007/s00018-017-2685-8WNT signaling, the development of the sympathoadrenal–paraganglionic system and neuroblastoma
resolves10.1038/onc.2012.106MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells
resolves10.1200/JCO.2007.12.3349Localized Infant Neuroblastomas Often Show Spontaneous Regression: Results of the Prospective Trials NB95-S and NB97
resolves10.1038/s41467-018-07580-5Transcriptome 3′end organization by PCF11 links alternative polyadenylation to formation and neuronal differentiation of neuroblastoma
resolves10.1002/pbc.24433Children's Oncology Group's 2013 blueprint for research: Neuroblastoma
resolves10.1200/JCO.2008.16.6785The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
resolves10.1007/s40272-017-0251-3Incidence, Survival, and Treatment of Localized and Metastatic Neuroblastoma in Germany 1979–2015
resolves10.1056/NEJM199910143411601Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-<i>cis</i>-Retinoic Acid
resolves10.1007/s12325-012-0047-3Retinoids in Pediatric Onco-Hematology: the Model of Acute Promyelocytic Leukemia and Neuroblastoma
resolves10.1002/ana.24659The “neuro” of neuroblastoma: <scp>N</scp>euroblastoma as a neurodevelopmental disorder
resolves10.1016/j.stem.2008.03.005Ontogeny and Multipotency of Neural Crest-Derived Stem Cells in Mouse Bone Marrow, Dorsal Root Ganglia, and Whisker Pad
resolves10.1371/journal.pone.0133897Expression of MYCN in Multipotent Sympathoadrenal Progenitors Induces Proliferation and Neural Differentiation, but Is Not Sufficient for Tumorigenesis
resolves10.1242/dev.127.13.2811Fate determination of neural crest cells by NOTCH-mediated lateral inhibition and asymmetrical cell division during gangliogenesis
resolves10.1073/pnas.1200421109Wnt5a–Ror–Dishevelled signaling constitutes a core developmental pathway that controls tissue morphogenesis
resolves10.1038/sj.onc.1203518Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells
resolves10.18632/oncotarget.18079Genomic analysis-integrated whole-exome sequencing of neuroblastomas identifies genetic mutations in axon guidance pathway
resolves10.1055/s-2000-9677Prognostic and Biological Role of Neurotrophin- Receptor TrkA and TrkB in Neuroblastoma1
resolves10.1186/gb-2006-7-9-r84Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes
resolves10.1038/sj.onc.1210769Deregulated Wnt/β-catenin program in high-risk neuroblastomas without MYCN amplification
resolves10.18632/oncotarget.10070Frizzled2 signaling regulates growth of high-risk neuroblastomas by interfering with β-catenin-dependent and β-catenin-independent signaling pathways
resolves10.1042/BSR20181277TRIM59 knockdown inhibits cell proliferation by down-regulating the Wnt/β-catenin signaling pathway in neuroblastoma
resolves10.1186/1756-9966-32-100XAV939, a tankyrase 1 inhibitior, promotes cell apoptosis in neuroblastoma cell lines by inhibiting Wnt/β-catenin signaling pathway
resolves10.18632/oncotarget.5548LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastoma
resolves10.1038/ng.3349Mutational dynamics between primary and relapse neuroblastomas
resolves10.1038/onc.2009.80The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/β-catenin pathway
resolves10.1002/pbc.22351Resistance of stem‐like cells from neuroblastoma cell lines to commonly used chemotherapeutic agents
resolves10.1097/CAD.0000000000000478Inhibition of WNT signaling reduces differentiation and induces sensitivity to doxorubicin in human malignant neuroblastoma SH-SY5Y cells
resolves10.1016/S1044-7431(03)00229-XGlycogen synthase kinase-3 and Axin function in a β-catenin-independent pathway that regulates neurite outgrowth in neuroblastoma cells
resolves10.7150/ijbs.3520Activated β-catenin Forces N2A Cell-derived Neurons Back to Tumor-like Neuroblasts and Positively Correlates with a Risk for Human Neuroblastoma
resolves10.1038/35017574Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation
resolves10.1158/1535-7163.MCT-13-0560-TGSK3 Inhibitors Regulate
<i>MYCN</i>
mRNA Levels and Reduce Neuroblastoma Cell Viability through Multiple Mechanisms, Including p53 and Wnt Signaling
resolves10.1007/s11060-010-0491-3GSK-3β inhibition promotes cell death, apoptosis, and in vivo tumor growth delay in neuroblastoma Neuro-2A cell line
resolves10.1016/j.devcel.2008.04.015Wnt3a and Dkk1 Regulate Distinct Internalization Pathways of LRP6 to Tune the Activation of β-Catenin Signaling
resolves10.1128/MCB.00177-10Ror2/Frizzled Complex Mediates Wnt5a-Induced AP-1 Activation by Regulating Dishevelled Polymerization
resolves10.1002/2211-5463.12594<scp>SLC</scp>34A2 promotes neuroblastoma cell stemness via enhancement of miR‐25/Gsk3β‐mediated activation of Wnt/β‐catenin signaling
resolves10.3892/etm.2014.1676Challenging role of Wnt5a and its signaling pathway in cancer metastasis (Review)
resolves10.1186/s12885-016-2293-2Planar cell polarity gene expression correlates with tumor cell viability and prognostic outcome in neuroblastoma
resolves10.1038/s41598-019-41299-7Non-canonical WNT-signaling controls differentiation of lymphatics and extension lymphangiogenesis via RAC and JNK signaling
resolves10.18632/oncotarget.410Frizzled receptor 6 marks rare, highly tumourigenic stem-like cells in mouse and human neuroblastomas
resolves10.1038/sj.onc.1205920Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas
resolves10.3892/ijo.2014.2406XAV939 inhibits the stemness and migration of neuroblastoma cancer stem cells via repression of tankyrase 1
resolves10.3892/or.2014.3460XAV939 promotes apoptosis in a neuroblastoma cell line via telomere shortening
resolves10.1002/ijc.23180<i>Dickkopf‐3</i> expression is a marker for neuroblastic tumor maturation and is down‐regulated by MYCN
checked 2026-07-25 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.